PL2418945T3 - Kompozycje soli mineralnej - kwasu sulfonowego i sposoby ich stosowania - Google Patents

Kompozycje soli mineralnej - kwasu sulfonowego i sposoby ich stosowania

Info

Publication number
PL2418945T3
PL2418945T3 PL10765221T PL10765221T PL2418945T3 PL 2418945 T3 PL2418945 T3 PL 2418945T3 PL 10765221 T PL10765221 T PL 10765221T PL 10765221 T PL10765221 T PL 10765221T PL 2418945 T3 PL2418945 T3 PL 2418945T3
Authority
PL
Poland
Prior art keywords
methods
sulfonic acid
acid compositions
mineral salt
mineral
Prior art date
Application number
PL10765221T
Other languages
English (en)
Inventor
William A. Goolsbee
Jeffrey L. Lillard
Original Assignee
Bmg Pharma S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bmg Pharma S P A filed Critical Bmg Pharma S P A
Publication of PL2418945T3 publication Critical patent/PL2418945T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/24—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing ingredients to enhance the sticking of the active ingredients
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/36—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N55/00—Biocides, pest repellants or attractants, or plant growth regulators, containing organic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen and sulfur
    • A01N55/02—Biocides, pest repellants or attractants, or plant growth regulators, containing organic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen and sulfur containing metal atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
PL10765221T 2009-04-15 2010-04-15 Kompozycje soli mineralnej - kwasu sulfonowego i sposoby ich stosowania PL2418945T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16954009P 2009-04-15 2009-04-15
EP10765221.6A EP2418945B1 (en) 2009-04-15 2010-04-15 Mineral salt-sulfonic acid compositions and methods of use
PCT/US2010/031319 WO2010121081A1 (en) 2009-04-15 2010-04-15 Mineral salt-sulfonic acid compositions and methods of use

Publications (1)

Publication Number Publication Date
PL2418945T3 true PL2418945T3 (pl) 2019-05-31

Family

ID=42982868

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10765221T PL2418945T3 (pl) 2009-04-15 2010-04-15 Kompozycje soli mineralnej - kwasu sulfonowego i sposoby ich stosowania

Country Status (8)

Country Link
US (5) US20120245080A1 (pl)
EP (2) EP2418945B1 (pl)
DK (1) DK2418945T3 (pl)
ES (1) ES2713349T3 (pl)
IL (1) IL215762A (pl)
PL (1) PL2418945T3 (pl)
PT (1) PT2418945T (pl)
WO (1) WO2010121081A1 (pl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2388281B1 (es) * 2010-12-27 2013-10-01 Laboratorios Viñas S.A. Composición farmacéutica que comprende ácido hialurónico y un compuesto de zinc y pastilla con palito y procedimiento para preparación correspondientes
EP2734159B1 (en) * 2011-07-21 2018-05-02 Peter Takacs Vaginal tissue rejuvenation compositions and methods
US9877929B2 (en) 2011-10-13 2018-01-30 Premier Dental Products Company Topical vitamin D and ubiquinol oral supplement compositions
US9877930B2 (en) 2012-10-12 2018-01-30 Premier Dental Products Company Topical ubiquinol oral supplement compositions with amorphous calcium phosphate
US9724542B2 (en) 2012-10-12 2017-08-08 Premier Dental Products Company Remineralizing and desensitizing compositions, treatments and methods of manufacture
ES2593618T3 (es) 2012-12-18 2016-12-12 Sunstar Suisse Sa Composición oral tópica para aliviar los síntomas de la boca seca y para el tratamiento de úlceras bucales
ES2472366B1 (es) * 2012-12-28 2015-05-06 Laboratorios Viñas S.A. Composición cosmética o farmacéutica en forma de gel acuoso que contiene ácido hialurónico para el tratamiento de la dispareunia
RU2693384C2 (ru) 2013-10-16 2019-07-02 Квест Продактс, ЛЛС Лечение повреждений слизистой оболочки с использованием гиалуронана, доставляемого из приклеивающейся пастилки
PL3138031T3 (pl) 2014-04-28 2023-04-11 Yeda Research And Development Co., Ltd. Sposób i urządzenie do przewidywania odpowiedzi na pokarm
EP3289093A4 (en) * 2015-04-28 2019-04-17 Yeda Research and Development Co., Ltd. USE OF MICROBIAL METABOLITES FOR THE TREATMENT OF DISEASES
WO2016205089A1 (en) 2015-06-17 2016-12-22 Profet Margaret Jean Topical and oral formulations comprising taurine and magnesium for the prevention and treatment of acne
CN105342987A (zh) * 2015-12-04 2016-02-24 亚飞（上海）生物医药科技有限公司 一种凝胶及其制备方法和应用
CN106913561B (zh) * 2015-12-25 2020-12-15 北京乳凝创智生物技术研发中心（有限合伙） 牛磺酸螯合钙在制备经皮吸收制剂中的应用
CA3030660C (en) * 2016-07-19 2023-01-17 National Institute Of Plant Genome Research Mutated protein from burkholderia gladioli strain ngj1 against fungal pathogens
IT201700058311A1 (it) * 2017-05-29 2018-11-29 Bio Lo Ga Srl Formulazione a base di vitamina E o di un suo estere per il trattamento di biofilm batterici e fungini
WO2019147877A1 (en) * 2018-01-26 2019-08-01 The Procter & Gamble Company Methods and compositions for reducing the feeling of vaginal dryness
US20200024329A1 (en) * 2018-07-17 2020-01-23 Bradley G. Thompson Methods for regulating endogenous production of lactoferrin and sub-peptides thereof
IT201800020416A1 (it) * 2018-12-20 2020-06-20 Neilos S R L Composizione per il trattamento delle disfunzioni sessuali femminili
EP3738588A1 (en) * 2019-05-13 2020-11-18 Margaret Jean Profet Topical and oral formulations comprising taurine and magnesium for use in the treatment of rosacea
IT202000004582A1 (it) * 2020-03-06 2021-09-06 Alfasigma Spa Composizione farmaceutica utile per il trattamento e la prevenzione dell’atrofia e della secchezza vaginale.
US11590073B2 (en) 2020-06-09 2023-02-28 The Procter & Gamble Company Methods and compositions for reducing the feeling of vaginal dryness
EP4188403A1 (en) * 2020-07-31 2023-06-07 Gary A. Gelbfish Treatment of bacterial vaginosis
KR20230080056A (ko) * 2021-11-29 2023-06-07 (주)아모레퍼시픽 릴린 및/또는 vegf-c의 생산 및/또는 활성 촉진제 및 이를 이용한 피부 외용제

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4229430A (en) 1978-08-21 1980-10-21 Fahim Mostafa S Oral composition for improving oral health
US4711780A (en) 1984-06-11 1987-12-08 Fahim Mostafa S Composition and process for promoting epithelial regeneration
US5075109A (en) 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
JPS63132820A (ja) 1986-11-22 1988-06-04 Minoru Nakano 口腔用組成物
US4897268A (en) 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
US4937234A (en) 1988-08-10 1990-06-26 Fahim Mostafa S Minerals in bioavailable form
US5700782A (en) * 1993-05-28 1997-12-23 Abbott Laboratories Enteral nutritional product
AU693312B2 (en) * 1995-01-18 1998-06-25 Taisho Pharmaceutical Co., Ltd. Remedy for dermatitis
FR2773488B1 (fr) 1998-01-12 2000-03-24 Fractales Biotech Nouvelles utilisations therapeutiques des superoxyde dismutases heterologues (hsd), ainsi que procede de selection desdites hsd
GB9801398D0 (en) 1998-01-22 1998-03-18 Anggard Erik E Chemical compounds
DE19860754B4 (de) 1998-06-24 2004-10-28 Coty B.V. Kosmetische Zubereitung
US6242473B1 (en) 1999-01-08 2001-06-05 Maxim Pharmaceuticals, Inc. Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
US6558710B1 (en) 1999-06-14 2003-05-06 Helen Rebecca Godfrey Topical zinc compositions and methods of use
EP1068871A1 (en) * 1999-07-07 2001-01-17 Jean-Paul Perraudin Novel methods and medicament for treating infections diseases involving microbial biofilms
US6828308B2 (en) 2000-07-28 2004-12-07 Sinclair Pharmaceuticals, Ltd. Compositions and methods for the treatment or prevention of inflammation
US6716813B2 (en) * 2000-11-28 2004-04-06 House Ear Institute Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis
US6884768B2 (en) * 2001-06-14 2005-04-26 Otsuka Pharmaceutical Co., Ltd. Medicinal compositions
US6906038B2 (en) * 2001-08-29 2005-06-14 Abbott Laboratories Methods for alleviating mucositis
US6930099B2 (en) * 2001-09-07 2005-08-16 Advanced Medical Instruments Composition for the treatment and prevention of endothelial dysfunction
US7563461B2 (en) * 2002-02-07 2009-07-21 The Trustees Of Columbia University In The City Of New York Zinc salt compositions for the prevention of dermal and mucosal irritation
DE60325353D1 (de) * 2002-05-21 2009-01-29 Abbott Lab Behandlung von mukositis
JP2005068060A (ja) * 2003-08-22 2005-03-17 Nrl Pharma Inc ラクトフェリンを含有する医薬組成物ならびに加工食品の製造法
CN1303989C (zh) * 2004-10-25 2007-03-14 北京科信必成医药科技发展有限公司 葡萄糖酸锌口腔崩解片及其制备工艺
WO2006047744A2 (en) 2004-10-26 2006-05-04 Agennix Incorporated Compositions of lactoferrin related peptides and uses thereof
US20060093675A1 (en) * 2004-10-29 2006-05-04 Mathew Ebmeier Intravaginal treatment of vaginal infections with metronidazole compositions
US20060127342A1 (en) * 2004-12-09 2006-06-15 Georgia Levis Taurine-based compositions, therapeutic methods, and assays
US20090076132A1 (en) * 2005-03-11 2009-03-19 Gary Pekoe Antiviral compositions and methods of treatment
ITMI20052351A1 (it) 2005-12-09 2007-06-10 Microbo Srl Nuovo uso farmaceutico delle transferrine e composizioni farmaceutiche derivate
BRPI0706925A2 (pt) * 2006-01-20 2011-04-19 Pera Tree Pharmaceuticals Inc composição farmacêutica para administração vaginal em um indivìduo e método para tratar sintomas urogenitais de vaginite atrófica
US20070292362A1 (en) 2006-05-15 2007-12-20 Tim Clarot Method for orthodontia care
GB0614353D0 (en) * 2006-07-20 2006-08-30 Oraldent Ltd Oral compositions, their preparation and use
US20130101642A1 (en) * 2011-10-20 2013-04-25 Texas Enterosorbents Inc. Methods and compositions for treating oral mucositis

Also Published As

Publication number Publication date
US20150190425A1 (en) 2015-07-09
EP2418945A1 (en) 2012-02-22
US20120245080A1 (en) 2012-09-27
EP2418945A4 (en) 2013-01-16
US10786531B2 (en) 2020-09-29
WO2010121081A1 (en) 2010-10-21
PT2418945T (pt) 2019-03-04
US20130337086A1 (en) 2013-12-19
DK2418945T3 (en) 2019-02-25
EP3406244A1 (en) 2018-11-28
EP3406244B1 (en) 2023-06-07
ES2713349T3 (es) 2019-05-21
EP3406244C0 (en) 2023-06-07
IL215762A0 (en) 2012-01-31
US20210015855A1 (en) 2021-01-21
US20190307792A1 (en) 2019-10-10
EP2418945B1 (en) 2018-12-05
IL215762A (en) 2017-11-30

Similar Documents

Publication Publication Date Title
IL215762A0 (en) Mineral salt-sulfonic acid compositions and methods of use
HRP20180497T1 (hr) Antimikrobni pripravci i odgovarajući postupci njihove upotrebe
EP2536756A4 (en) HSA-RELATED COMPOSITIONS AND USE PROCESSES
EP2584897A4 (en) COMPOSITIONS CONTAINING RESVERATROL AND METHODS OF USE
IL217280A0 (en) Compositions comprising combinations of phyto-cannabinoids and uses thereof
EP2448581A4 (en) THERAPEUTIC COMPOSITIONS AND METHODS OF USE THEREOF
EP2569425A4 (en) ENDORIBONUCLEASE COMPOSITIONS AND METHOD FOR THEIR USE
EP2429521A4 (en) SUBLINGUAL DEXMEDETOMIDINE COMPOSITIONS AND METHODS OF USE
IL222291A0 (en) Compositions and methods of synthesis of pyridinoylpiperidine
EP2596112A4 (en) ACETYCYSTEIN COMPOSITIONS AND USE METHOD THEREFOR
IL225227A0 (en) Preparations including fulvestrant and methods of use
EP2384120A4 (en) AUXILIARY COMPOSITIONS AND METHOD FOR THEIR USE
EP2438079A4 (en) NUCLEIC ACID DELIVERY COMPOSITIONS AND METHOD OF USE THEREOF
EP2231665A4 (en) NEW COMPOSITIONS AND METHODS OF USE
EP2506709A4 (en) AMANTADIN COMPOSITIONS AND METHODS OF USE THEREOF
EP2515647A4 (en) PHEROMONIC COMPOSITIONS AND METHODS OF USE
EP2501414A4 (en) SMNDELTA7 DEGRON: NEW COMPOSITIONS AND METHODS OF USE
EP2496240A4 (en) APATITE COMPOSITIONS AND METHODS OF USE
EP2622029A4 (en) PRINTING COLORING COMPOSITIONS AND METHOD FOR THEIR USE
IL247929B (en) Stable compositions of 595–sns and methods for their preparation
EP2416796A4 (en) Modified dnase compositions and methods of use thereof
HK1166953A1 (en) Compositions and methods of use
EP2411020A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF HEMORRHAGE
ZA201300041B (en) Methods and compositions of beneficiation
AU2009905941A0 (en) Improved mineral based composition and methods of use